Clinical Trial Update: MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy [NA]

View source ↗

Summary

Completed clinical trial evaluating MC5-A Scrambler Therapy or TENS Therapy for chemotherapy-induced peripheral neuropathy; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• MC5-A Scrambler Therapy
• Transcutaneous Electrical Nerve Stimulation (TENS) Therapy (TENS)

Snippet

Sponsor: Mayo Clinic | Conditions: Pain, Peripheral Neuropathy | NA | Status: COMPLETED | Results posted: 2022-01-12